Molecular mechanisms of thrombolysis: implications for therapy. - Suppr | 超能文献

Molecular mechanisms of thrombolysis: implications for therapy.

作者信息

Collen D, Lijnen H R

机构信息

Center for Thrombosis and Vascular Research, University of Leuven, Belgium.

出版信息

Biochem Pharmacol. 1990 Jul 15;40(2):177-86. doi: 10.1016/0006-2952(90)90676-c.

DOI:10.1016/0006-2952(90)90676-c

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Molecular mechanisms of thrombolysis: implications for therapy.

Biochem Pharmacol. 1990 Jul 15;40(2):177-86. doi: 10.1016/0006-2952(90)90676-c.

2

The search for the ideal thrombolytic agent.对理想溶栓剂的探索。

J Am Coll Cardiol. 1987 Nov;10(5 Suppl B):4B-10B. doi: 10.1016/s0735-1097(87)80421-7.

3

[Acyl enzymes and pro-urokinase: promising new thrombolytic agents].[酰基酶和前尿激酶：有前景的新型溶栓剂]

Haemostasis. 1986;16 Suppl 4:35-9. doi: 10.1159/000215530.

4

[Thrombolytic therapy].[溶栓治疗]

Nihon Rinsho. 1998 Oct;56(10):2577-81.

5

Is the streptokinase responsible for the endothelial injury and the platelet activation during fibrinolytic therapy?

J Intern Med. 2001 May;249(5):475-6. doi: 10.1046/j.1365-2796.2001.0825a.x.

6

[Thrombolytics and their use].[溶栓剂及其应用]

Rev Prat. 1999 Oct 1;49(15):1654-8.

7

Coronary thrombolysis with clot-selective plasminogen activators.使用凝块选择性纤溶酶原激活剂进行冠状动脉溶栓治疗。

Herz. 1986 Feb;11(1):9-15.

8

Validity of the GUSTO trial's main conclusion. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronaries.GUSTO试验主要结论的有效性。全球链激酶和组织型纤溶酶原激活剂用于闭塞冠状动脉的研究。

Pharmacotherapy. 1997 Jul-Aug;17(4):850-2.

9

Thrombolytic therapy.溶栓治疗。

Ann N Y Acad Sci. 1991;614:259-69. doi: 10.1111/j.1749-6632.1991.tb43708.x.

10

Neuraxial bleeding: fibrinolytics/thrombolytics.椎管内出血：纤溶药物/溶栓药物。

Reg Anesth Pain Med. 1998 Nov-Dec;23(6 Suppl 2):152-6. doi: 10.1016/s1098-7339(98)90141-9.

引用本文的文献

1

Amino-Terminal Fusion of Epidermal Growth Factor 4,5,6 Domains of Human Thrombomodulin on Streptokinase Confers Anti-Reocclusion Characteristics along with Plasmin-Mediated Clot Specificity.人血栓调节蛋白表皮生长因子4、5、6结构域与链激酶的氨基末端融合赋予抗再闭塞特性以及纤溶酶介导的凝块特异性。

PLoS One. 2016 Mar 14;11(3):e0150315. doi: 10.1371/journal.pone.0150315. eCollection 2016.